Tonghua Golden-Horse Pharmaceutical Industry (000766.SZ) Earnings Analysis
Tonghua Golden-Horse Pharmaceutical Industry (000766.SZ) has no confirmed upcoming earnings date. Trailing P/E 478.66.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000766.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 000766.SZ. This page updates as the calendar is published.
000766.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-03-31 | 0.012 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.03364 CNY | n/a | n/a | n/a |
| 2024-09-29 | 0.01185 CNY | n/a | n/a | n/a |
000766.SZ valuation and analyst view
| Trailing P/E | 478.66 |
|---|---|
| Trailing EPS | 0.03278 CNY |
| Price / book | 6.57 |
| Dividend yield | 0.00% |
| Market cap | 15.39B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tonghua Golden-Horse Pharmaceutical Industry (000766.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 000766.SZ. This page updates as the calendar is published.
Did 000766.SZ beat earnings last quarter?
Consensus estimate data was not available for 000766.SZ's 2025-03-31 report.
What is 000766.SZ's current P/E ratio and EPS?
000766.SZ trades at a trailing P/E of 478.66 on trailing EPS of 0.032776912582898506 CNY.
What do analysts rate 000766.SZ?
000766.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.